Attached files
| file | filename |
|---|---|
| EX-10.10 - EX-10.10 - Avidity Biosciences, Inc. | rna-ex1010_622.htm |
| EX-32.2 - EX-32.2 - Avidity Biosciences, Inc. | rna-ex322_6.htm |
| EX-32.1 - EX-32.1 - Avidity Biosciences, Inc. | rna-ex321_7.htm |
| EX-31.2 - EX-31.2 - Avidity Biosciences, Inc. | rna-ex312_8.htm |
| EX-31.1 - EX-31.1 - Avidity Biosciences, Inc. | rna-ex311_9.htm |
| EX-10.14 - EX-10.14 - Avidity Biosciences, Inc. | rna-ex1014_621.htm |
| EX-10.4 - EX-10.4 - Avidity Biosciences, Inc. | rna-ex104_840.htm |
| EX-4.3 - EX-4.3 - Avidity Biosciences, Inc. | rna-ex43_839.htm |
| 10-K - 10-K - Avidity Biosciences, Inc. | rna-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Avidity Biosciences, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-239148) of Avidity Biosciences, Inc., of our report dated March 15, 2021, relating to the financial statements, which appears in this annual report on Form 10-K.
/s/ BDO USA, LLP
San Diego, California
March 15, 2021